G6PD and cyclic hematopoiesis: In 2011, the National Neonatology Forum (NNF) recommended congenital hypothyroidism (CH), congenital adrenal hyperplasia (CAH), and glucose-6-phosphate dehydrogenase (G6PD) deficiency as the screening panel to implement for newborn screening in India [2].